Calcium bis(cyclohexylsulphamate)

Modify Date: 2024-01-08 11:27:29

Calcium bis(cyclohexylsulphamate) Structure
Calcium bis(cyclohexylsulphamate) structure
Common Name Calcium bis(cyclohexylsulphamate)
CAS Number 139-06-0 Molecular Weight 396.53700
Density N/A Boiling Point N/A
Molecular Formula C12H24CaN2O6S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Calcium bis(cyclohexylsulphamate)
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C12H24CaN2O6S2
Molecular Weight 396.53700
Exact Mass 396.07000
PSA 155.22000
LogP 3.68120

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GV7100000
CAS REGISTRY NUMBER :
139-06-0
LAST UPDATED :
199710
DATA ITEMS CITED :
23
MOLECULAR FORMULA :
C12-H24-N2-O6-S2.Ca
MOLECULAR WEIGHT :
396.58
WISWESSER LINE NOTATION :
L6TJ AMSWO 2 &-CA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
291 gm/kg/35D-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3465 gm/kg/88W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
45 gm/kg/66W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
55 mg/kg
SEX/DURATION :
female 1-22 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - other postnatal measures or effects
TYPE OF TEST :
Sex chromosome loss and nondisjunction

MUTATION DATA

TEST SYSTEM :
Rodent - gerbil
DOSE/DURATION :
150 mg/kg
REFERENCE :
CNJGA8 Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- Volume(issue)/page/year: 13,189,1971 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 22,55,1980 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 22,55,1980 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,178,1987 TOXICOLOGY REVIEW MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 39,1,1976 TOXICOLOGY REVIEW WMWOA4 Wiener Medizinische Wochenschrift. (Brueder Hollinek, Gallgasse 40, A-1130 Vienna, Austria) V.1- 1851- Volume(issue)/page/year: 121,515,1971

 Safety Information

Hazard Codes Xn
Risk Phrases R36/37/38
Safety Phrases 26-36
RTECS GV7100000

 Synonyms

calciumsucaryl
cacyclamate
cyclamate,calciumsalt
CYCLAMATE CALCIUM
cylan
kalziumzyklamate
CALCIUM CYCLAMATE
cyclan
dietil
sucarylcalcium
EINECS 205-349-4
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Calcium bis(cyclohexylsulphamate) suppliers

Calcium bis(cyclohexylsulphamate) price

Related Compounds: More...
calcium bis[4-[[3-[[2-hydroxy-3-[[(4-methoxyphenyl)amino]carbonyl]-1-naphthyl]azo]benzoyl]amino]benzenesulphonate]
69898-39-1
calcium bis[6-chloro-4-[[2-hydroxy-3-[(2-methoxyphenyl)carbamoyl]-1-naphthyl]azo]toluene-3-sulphonate]
85702-54-1
calcium bis(4-hydroxybenzoate)
69959-44-0
Calcium bis(trifluoromethylsulfonyl)imide
165324-09-4
calcium bis(tetrapropylenebenzenesulphonate)
11117-11-6
calcium bis[6-chloro-4-[(2-hydroxy-1-naphthyl)azo]toluene-3-sulphonate]
67801-02-9
calcium bis[5-hydroxy-6-(naphthylazo)naphthalenesulphonate]
6373-10-0
calcium bis[4-[[3-[[2-hydroxy-3-[[(4-methoxyphenyl)amino]carbonyl]-1-naphthyl]azo]-4-methylbenzoyl]amino]benzenesulphonate]
43035-18-3
calcium bis[3-nitro-4-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulphonate]
12286-65-6
({[2-(Trifluoromethyl)phenyl]methyl}carbamoyl)methyl 4-methoxybenzoate
1524717-55-2
({[2-(Trifluoromethyl)phenyl]methyl}carbamoyl)methyl 2-ethoxybenzoate
1794844-14-6
2-((4-Bromobenzyl)amino)-2-oxoethyl 2-ethoxybenzoate
1794935-31-1
{[(4-Bromophenyl)methyl]carbamoyl}methyl 3,4-diethoxybenzoate
1794785-33-3
{[(2,4-Difluorophenyl)methyl]carbamoyl}methyl 3,4-diethoxybenzoate
1794851-58-3
2-((2,4-Difluorobenzyl)amino)-2-oxoethyl 5-bromofuran-2-carboxylate
1794741-78-8
{[1-(4-Methoxyphenyl)ethyl]carbamoyl}methyl 5-bromofuran-2-carboxylate
1794851-40-3
2-((2-Chloro-5-fluorophenyl)amino)-2-oxoethyl 5-bromofuran-2-carboxylate
1794798-79-0
({[2-(Trifluoromethyl)phenyl]methyl}carbamoyl)methyl 3,4,5-triethoxybenzoate
1794851-30-1
{[(2,4-Difluorophenyl)methyl]carbamoyl}methyl 3,4,5-triethoxybenzoate
1794883-87-6